Clinical Trials on Atherosclerotic Cardiovascular Disease (ASCVD) in New Zealand

Total 5927 results

Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

Taiwan, United States, Spain, Argentina, China, Italy, Australia, France, Canada, Japan, Belgium, Denmark, Germany, Hungary, Israel, Austria, Korea, Republic of, Brazil, Mexico, Netherlands, Romania, United Kingdom, Greece, Czechia, India, Slovak... and more
The Medicines Company

Completed

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol (ORION-10)

Elevated Cholesterol | ASCVD

United States
Novo Nordisk A/S

Enrolling by invitation

A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Systemic Inflammation | Chronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)

United States
Verve Therapeutics, Inc.

Not yet recruiting

Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial Hypercholesterolemia

New Zealand, United Kingdom
Verve Therapeutics, Inc.

Active, not recruiting

A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease

Hypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial Hypercholesterolemia

New Zealand, United Kingdom
Endologix

Completed

PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass (PQB4FP1)

Peripheral Arterial Disease

New Zealand
Avinger, Inc.

Withdrawn

Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries (COMBINE-II)

Peripheral Arterial Disease

New Zealand
Terumo Medical Corporation

Recruiting

Kaitoh Atherectomy FIH

Peripheral Arterial Disease

New Zealand
Spectranetics Corporation

Completed

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: (PK)

Peripheral Artery Disease

New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
W.L.Gore & Associates

Completed

Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX)

Peripheral Arterial Disease | Common Iliac Artery Occlusive Disease | External Iliac Artery Occlusive Disease

New Zealand
Yale University

Completed

Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)

High Risk Atherosclerotic Cardiovascular Disease

United States
Genentech, Inc.
BioInvent International AB

Completed

A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)

Atherosclerosis

United States, Canada
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
TriReme Medical, LLC

Completed

Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial (ENDURE)

Peripheral Vascular Disease

New Zealand, Germany
Duke University
Patient-Centered Outcomes Research Institute; Research Action for Health Network... and other collaborators

Completed

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term (ADAPTABLE)

Atherosclerotic Cardiovascular Disease

United States
Amgen
Duke Clinical Research Institute

Terminated

The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) (cvMOBIUS)

ASCVD

United States, Canada
480 Biomedical

Completed

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (STANCE)

Atherosclerosis of Femoral Artery | Superficial Femoral Artery Lesions

New Zealand, Austria, Australia, Germany
NewAmsterdam Pharma
Monash University

Recruiting

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

Atherosclerotic Cardiovascular Disease

United States, Israel, Italy, Spain, Canada, Czechia, Poland, China, Denmark, Netherlands, Finland, Japan, Australia, Hungary, Germany, Croatia, United Kingdom, Bulgaria, South Africa, Georgia, Jordan, Slovakia, Latvia
Cagent Vascular LLC

Completed

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (PRELUDE)

Peripheral Arterial Disease

New Zealand, Austria, Poland
Novo Nordisk A/S

Completed

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Atherosclerotic Cardiovascular Disease

Germany, Poland, United States, Netherlands, Japan, Greece, Belgium
Shockwave Medical, Inc.

Completed

Safety and Performance Study of the Shockwave Lithoplasty System (DISRUPT-PAD)

Peripheral Arterial Disease

Austria, Germany, New Zealand
Northwell Health

Active, not recruiting

The Young Heart Study

Coronary Artery Disease | Atherosclerotic Cardiovascular Disease

United States
ReFlow Medical, Inc.
ClinLogix. LLC

Active, not recruiting

A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee (DEEPER OUS)

Peripheral Arterial Disease

New Zealand, Germany, Switzerland
Icahn School of Medicine at Mount Sinai
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Completed

Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study (CIRT)

Atherosclerotic Cardiovascular Disease | Vascular Inflammation

United States, Canada
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
Shockwave Medical, Inc.

Completed

Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)

Peripheral Arterial Disease

New Zealand, Germany, Austria
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
Cook Group Incorporated

Completed

Zilver PTX Delivery System

Peripheral Vascular Disease

New Zealand, Australia, Germany
Biotronik CRC Inc.
Biotronik AG

Active, not recruiting

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Boston Scientific Corporation

Completed

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Coronary Artery Disease | Atherosclerosis

Singapore, Australia, New Zealand
Esperion Therapeutics, Inc.

Completed

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Hypercholesterolemia | Atherosclerotic Cardiovascular Diseases

United States, United Kingdom, Germany, Poland, Netherlands, Canada
Shockwave Medical, Inc.

Completed

Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis (BTK)

Peripheral Arterial Disease

New Zealand, Austria, Germany
Amgen

Completed

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Atherosclerotic Cardiovascular Disease

Canada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
Novartis Pharmaceuticals

Active, not recruiting

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Atherosclerotic Cardiovascular Disease

United States, China, South Africa, Spain, Austria, Belgium, Croatia, Estonia, Hungary, Taiwan, Turkey, Netherlands, Italy, Australia, Czechia, Denmark, France, Israel, Korea, Republic of, Thailand, Argentina, Bulgaria, Greece, Romania, Sloveni... and more
Rijnstate Hospital

Terminated

Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) for Extensive Aortoiliac Occlusive Disease

Aorto-Iliac Atherosclerosis | Aortoiliac Obstruction

New Zealand, Italy, Netherlands, Australia, Mexico
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, Canada, France, Netherlands, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South Africa and more
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
PQ Bypass, Inc.

Unknown

DETOUR I Clinical Study

Peripheral Arterial Disease

Italy, Chile, Germany, Latvia, New Zealand, Poland
Klinikum Rosenheim
Charite University, Berlin, Germany; Medtronic; University Hospital Tuebingen; Herz-Zentrums... and other collaborators

Unknown

CHOCO-CABANA Trial

Atherosclerosis

New Zealand, Austria, Germany
Novartis Pharmaceuticals

Completed

A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) (V-INITIATE)

Atherosclerotic Cardiovascular Disease

United States
NYU Langone Health

Completed

Subclinical Cardiovascular Disease in Psoriatic Disease

Myocardial Infarction | Cardiovascular Diseases | Atherosclerotic Cardiovascular Disease | Thrombotic Vascular Disease

United States
Elixir Medical Corporation
Massachusetts General Hospital; Syntactx; Genae

Completed

The DESappear Study: Drug Eluting Scaffold (DESappear)

Peripheral Vascular Disease

New Zealand, Austria, Germany, Belgium
Symic Vascular
Symic Biomedical, Inc.

Unknown

Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis (SHIELD)

Peripheral Arterial Disease

Australia, New Zealand
AstraZeneca
The Cleveland Clinic; IQVIA RDS Inc.

Completed

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH)

Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
Cagent Vascular LLC

Completed

The PRELUDE BTK Study

Peripheral Arterial Disease | Critical Limb Ischemia

New Zealand, Austria, Germany, Poland
C. R. Bard

Terminated

Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LEG)

Peripheral Artery Disease

Malaysia, New Zealand, Canada
Cook Group Incorporated

Completed

Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)

Peripheral Arterial Disease (PAD)

Germany, New Zealand

3

Subscribe